Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021
Author:
Affiliation:
1. COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia
2. Westat, Rockville, Maryland
3. Vitalant Research Institute, San Francisco, California
4. Scientific Affairs, American Red Cross, Gaithersburg, Maryland
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2793517/jama_jones_2022_ld_220041_1657919756.39209.pdf
Reference5 articles.
1. Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021.;Jones;JAMA,2021
2. SARS-CoV-2 Omicron variant: recent progress and future perspectives.;Fan;Signal Transduct Target Ther,2022
3. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 states, August 2021-January 2022.;Ferdinands;MMWR Morb Mortal Wkly Rep,2022
4. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection.;Hall;N Engl J Med,2022
5. Centers for Disease Control and Prevention. COVID data tracker. Accessed March 23, 2022. https://covid.cdc.gov/covid-data-tracker
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SARS-COV-2 breakthrough infection and its covariates among healthcare providers of a hospital in Bangladesh during the omicron wave;Heliyon;2024-09
2. Higher intraindividual variability of body mass index is associated with elevated risk of COVID-19 related hospitalization and post-COVID conditions;International Journal of Obesity;2024-08-12
3. Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors;Emerging Infectious Diseases;2024-08
4. Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for Covid-19;New England Journal of Medicine;2024-07-18
5. SARS‐CoV‐2 antibody levels and long COVID occurrence in blood donors;Transfusion;2024-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3